亚细胞器官向作为一种新的方法来对抗瘤转移
Zefan Liu1, Yang Liu1, Xin Kang1
1Department of General Surgery, First People's Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu 610200, China.
Pharmaceutics
|February 26, 2025
概括
针对参与瘤转移的亚细胞器官提供了癌症治疗的新策略. 本综述探讨了特定于有机体的输送方法,以提高药物的疗效,减少治疗癌症扩散的副作用.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤转移是一种复杂的过程,涉及癌细胞扩散到遥远的器官.
- 在转移期间,亚细胞器官经历了显著的变化,影响了癌症的进展.
- 准这些细胞器是一个精确的治疗策略,以改善药物输送和疗效.
研究的目的:
- 审查瘤转移和亚细胞器官之间的复杂关系.
- 阐明针对抗转移疗法的有机体特定向策略.
- 讨论针对器官细胞的转移治疗的未来前景.
主要方法:
- 关于瘤转移机制的综合文献综述.
- 对癌症扩散中的亚细胞器官功能进行分析.
- 评估各种针对器官细胞输送的向策略.
主要成果:
- 亚细胞器官在多个阶段的瘤转移中发挥着关键作用.
- 目前正在开发多种向策略,包括生物膜和,用于器官细胞的输送.
- 精确准提高了治疗效果,并最大限度地减少了非准效应.
结论:
- 针对有机细胞的疗法在改善癌症转移治疗方面具有显著的前景.
- 了解器官的作用,可以实现转移级联的多阶段破坏.
- 对向策略的进一步研究可以导致更有效的抗癌药物.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotaxis and Direction of Cell Migration
3.3K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.3K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K


